Platinex

10 mg

50 mg

Platinex 10 mg Injection (10 mL vial)

• Indications: Treatment of ovarian, testicular, and bladder cancers—and sometimes cervical cancer—under close medical supervision .

• Administration: Administered slowly IV in hospital/clinic by qualified staff; dosing varies per protocol 

• Key side effects: Injection-site pain/swelling, nausea/vomiting, nephrotoxicity (kidney), ototoxicity (hearing loss/ringing), bone marrow suppression (low blood counts), peripheral neuropathy (numbness/tingling), electrolyte imbalance .

• Warnings: Avoid in renal/hepatic impairment, pregnancy, breastfeeding; causes infertility in men; monitor labs (kidney, hearing, CBC) during treatment 

• Storage: Below 25 °C 

Platinex 50 mg Infusion (50 mL or 50 mg vial)

• Indications: Similar cancers—ovarian, testicular, bladder—plus potential use for lung, cervical, head & neck cancers 

• Administration & monitoring: Given IV by healthcare professionals; important to ensure adequate hydration and check kidney function, CBC, hearing before and during therapy 

• Side effects: Injection-site reactions, nephrotoxicity, ototoxicity, myelosuppression, nausea/vomiting, neuropathy; also risk of electrolyte disturbances and allergic reactions .

• Warnings: Contraindicated in renal impairment, pregnancy, breastfeeding; requires frequent lab and audiometry monitoring .

• Storage: 15–25 °C .

---

✅ Patient Counseling & Safety Points

• Administration: IV only, under medical supervision—never self-administer.

• Hydration: Essential before and after infusion to reduce kidney damage risk.

• Lab monitoring: Vital to check kidney/liver function, CBC, and hearing periodically.

• Fertility & pregnancy: Teratogenic, causes male infertility—consider sperm banking; avoid in pregnancy and lactation 

• Common side effects management: Anti-nausea meds prescribed; hydration; skin care and ear monitoring recommended.

• Avoid: Alcohol (may worsen side effects), nephrotoxic or ototoxic concurrent medications.

---

📋 Summary Comparison